Raman-modes of index-identified free-standing single-walled carbon nanotubes

Using electron diffraction on free-standing single-walled carbon nanotubes we have determined the structural indices (n,m) of tubes in the diameter range from 1.4 to 3nm. On the same free-standing tubes we have recorded Raman spectra of the tangential modes and the radial breathing mode. For the smaller diameters (1.4-1.7nm) these measurements confirm previously established radial breathing mode frequency versus diameter relations, and would be consistent with the theoretically predicted proportionality to the inverse diameter. However, for extending the relation to larger diameters, either a yet unexplained environmental constant has to be assumed, or the linear relation has to be abandoned.Comment: 4 pages, 4 figures, +additional materials (select PostScript to obtain it

PART is part of Alzheimer disease

It has been proposed that tau aggregation confined to entorhinal cortex and hippocampus, with no or only minimal Aβ deposition, should be considered as a 'primary age-related tauopathy' (PART) that is not integral to the continuum of sporadic Alzheimer disease (AD). Here, we examine the evidence that PART has a pathogenic mechanism and a prognosis which differ from those of AD. We contend that no specific property of the entorhinal-hippocampal tau pathology makes it possible to predict either a limited progression or the development of AD, and that biochemical differences await an evidence base. On the other hand, entorhinal-hippocampal tau pathology is an invariant feature of AD and is always associated with its development. Rather than creating a separate disease entity, we recommend the continued use of an analytical approach based on NFT stages and Aβ phases with no inference about hypothetical disease processes.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Slutrapport. Temaforskningsprogram Vilt och Skog 2010-2012

Liksom under föregående projektperiod har styrgruppen under 2010‐12 varit mycket engagerad och aktiv. För tema 1 ‐ Klövviltets fördelning och nyttjande av skogslandskapet ‐ har det inneburit ett fortsatt fokus på älg fram till 2012 då programmet startade förberedelserna för flerartsstudier. För tema 2 ‐ Skogsskötsel, foderproduktion och utnyttjande – har det medfört dels ett fortsatt fokus utvärdering av åtgärderna i Sveaskogs foderprojekt, dels ett tydligare arbete med fler studieområden och klövviltets nyttjande av miljön. För tema 3 ‐ Förbättrade instrument för övervakning av viltpopulationerna – har resurserna koncentrerats på studier av referenshägn. Utifrån rogrammets resurser, >3 Mkr per år, och den ambitiösa programplanen som styrgruppen tillsammans med forskarna utarbetat, är det programledningens bedömning att vi mer än väl nått målen vad gäller relevant kunskap för sektorn och SLU, särskilt inom följande områden. Vi har… * med flera studiepopulationer i södra, mellersta och norra Sverige studerat älgarnas fördelning och nyttjande av skogslandskapet med hjälp av GPS; * med tre studiepopulationer i södra Sverige studerat klövviltets fördelning och nyttjande av skogslandskapet med hjälp av inventeringar; * dokumenterat nyttjandet ur ett flerartsperspektiv i tre områden i södra Sverige; * utvärderat effekten på skog av direkt foderskapande åtgärder inklusive viltåkrar; * i stor skala utvecklat och utvärderat metoder för uppföljning av klövviltets fördelning i landskapet och deras påverkan; * etablerat och delvis utvärderat referenshägn som ett förbättrat instrument för bedömning av betespåverkan; * i de två regeringsuppdragen till SLU om inventeringsmetoder för älg och utbildning adaptiv förvaltning utarbetat faktablad, manualer och utbildningsmaterial, samt deltagit i utbildning av länsstyrelser och skogsnäring Vi bedömer att vi endast delvis nått målen för… * några planerade foderskapande åtgärder. Vi bedömer att orsaken till detta är rent praktiska inom skogssektorn, vilka stått helt utanför vår kontroll. Det handlar dels om att åtgärderna sattes in så sent (säsongen 2010‐2011 eller 2012 för frihuggning av ekar) att effekterna helt enkelt inte kunnat utvärderas (främst viltanpassad röjning), dels att planerade åtgärder som plantering av salix inte alls blev av, dels att vissa åtgärder utfördes i mycket mindre omfattning än planerat; * förbättrade instrument för övervakning av viltpopulationerna. SLU:s och den skogsvetenskapliga fakultetens mål med temaforskningsprogram är att bygga ny kompetens. Under programperioden har SLU blivit den ledande miljön inom adaptiv klövviltförvaltning, rörelseekologi, vilt och foderskapande åtgärder samt inventeringsmetodik för betning och klövvilt. Programmet har tränat fyra postdoktorala forskare varav två är docent på SLU idag. Vi har internationellt rekryterat två forskarassistenter som redan nu efter två år är under prövning för docentur vid SLU. Programet har tränat 22 studenter, sammanfattat kunskapen i 17 rapporter, 22 examensarbeten (21 master, 1 kandidat), 15 faktablad, 7 bokkapitel, 6 manualer för adaptiv 4 älgförvaltning, 6 instruktioner om försöksdesign, >11 populärvetenskapliga artiklar och slutligen 51 vetenskapliga arbeten till refereegranskade tidskrifter. Därtill har vi medverkat i ett stort antal publika möten från Skåne i söder till Norrbotten i norr

Visualization of membrane loss during the shrinkage of giant vesicles under electropulsation

We study the effect of permeabilizing electric fields applied to two different types of giant unilamellar vesicles, the first formed from EggPC lipids and the second formed from DOPC lipids. Experiments on vesicles of both lipid types show a decrease in vesicle radius which is interpreted as being due to lipid loss during the permeabilization process. We show that the decrease in size can be qualitatively explained as a loss of lipid area which is proportional to the area of the vesicle which is permeabilized. Three possible mechanisms responsible for lipid loss were directly observed: pore formation, vesicle formation and tubule formation.Comment: Final published versio

Interferon (IFN)-γ-Inducible Protein-10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN-α2a and Ribavirin for Chronic Hepatitis C Virus Infection

BackgroundWe investigated associations between interferon (IFN)-γ-inducible protein (IP)-10 and liver histological results, viral kinetic response, and treatment outcome in patients infected with hepatitis C virus (HCV) genotypes 1-4 MethodsPlasma IP-10 was monitored before, during, and after treatment with pegylated IFN-α2a and ribavirin in 265 HCV-infected patients ResultsIn univariate analyses, a low baseline IP-10 level was significantly associated with low baseline viral load, rapid viral response (RVR), a sustained viral response (SVR), body mass index <25 kg/m2, and less-pronounced fibrosis, inflammation, and steatosis (for HCV genotypes other than 3). When the results of the univariate analyses were included in multivariate analyses, a low plasma IP-10 level, low baseline viral load, and genotype 2 or 3 infection were independent predictors of an RVR and SVR. IP-10 levels decreased 6 weeks into treatment and remained low in patients with an SVR. By contrast, plasma levels of IP-10 rebounded in patients who had detectable HCV RNA after the completion of treatment. Using cutoff IP-10 levels of 150 and 600 pg/mL for predicting an SVR in patients infected with HCV genotype 1 yielded a specificity and sensitivity of 81% and 95%, respectively ConclusionBaseline IP-10 levels are predictive of the response to HCV treatmen

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels were observed in patients achieving a rapid viral response (RVR) (P &lt; .0001), even in those with body mass index (BMI) ≥ 25 kg/m2 (P = .004) and with baseline viral load ≥ 2 million IU/mL (P = .001). Similarly, significantly lower IP-10 levels were observed in patients obtaining a sustained viral response (SVR) (P = .0002), including those having higher BMI (P &lt; .05), higher viral load (P = .0005), and both higher BMI and viral load (P &lt; .03). In multivariate logistic regression analyses, a low IP-10 value was independently predictive of both RVR and SVR. A baseline cutoff IP-10 value of 600 pg/mL yielded a negative predictive value (NPV) of 79% (19/24) for all genotype 1-infected patients, which was comparable with that observed using a reduction in HCY-RNA by at least 2 logs after 12 weeks of therapy (NPV 86%; 19/22); by combining the two, 30 of 38 patients (NPV 79%) potentially could have been spared unnecessary therapy. In patients having both higher BMI and viral load, cut-off levels of 150 and 600 pg/mL yielded a positive predictive value (PPV) of 71% and NPV of 100%, respectively. In conclusion, pretreatment IP-10 levels predict RVR and SVR in patients infected with HCV genotype 1, even in those with higher BMI and viral load. A substantial proportion of the latter patients may achieve SVR in spite of unfavorable baseline characteristics if their pretreatment IP-10 level is low. Thus, pretreatment IP-10 analysis may prove helpful in decision-making regarding pharmaceutical intervention.</p

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

Background: Hepatitis C decreases health related quality of life (HRQL) which is further diminished by antiviral therapy. HRQL improves after successful treatment. This trial explores the course of and factors associated with HRQL in patients given individualized or standard treatment based on early treatment response (Ditto-study). Methods: The Short Form (SF)-36 Health Survey was administered at baseline (n = 192) and 24 weeks after the end of therapy (n = 128). Results: At baseline HRQL was influenced by age, participating center, severity of liver disease and income. Exploring the course of HRQL (scores at follow up minus baseline), only the dimension general health increased. In this dimension patients with a relapse or sustained response differed from non-responders. Men and women differed in the dimension bodily pain. Treatment schedule did not influence the course of HRQL. Conclusions: Main determinants of HRQL were severity of liver disease, age, gender, participating center and response to treatment. Our results do not exclude a more profound negative impact of individualized treatment compared to standard, possibly caused by higher doses and extended treatment duration in the individualized group. Antiviral therapy might have a more intense and more prolonged negative impact on females

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior to treatment with pegylated interferon-α-2a and ribavirin. Significantly lower IP-10 levels were observed in patients achieving a rapid viral response (RVR) (P &lt; .0001), even in those with body mass index (BMI) ≥ 25 kg/m2 (P = .004) and with baseline viral load ≥ 2 million IU/mL (P = .001). Similarly, significantly lower IP-10 levels were observed in patients obtaining a sustained viral response (SVR) (P = .0002), including those having higher BMI (P &lt; .05), higher viral load (P = .0005), and both higher BMI and viral load (P &lt; .03). In multivariate logistic regression analyses, a low IP-10 value was independently predictive of both RVR and SVR. A baseline cutoff IP-10 value of 600 pg/mL yielded a negative predictive value (NPV) of 79% (19/24) for all genotype 1-infected patients, which was comparable with that observed using a reduction in HCY-RNA by at least 2 logs after 12 weeks of therapy (NPV 86%; 19/22); by combining the two, 30 of 38 patients (NPV 79%) potentially could have been spared unnecessary therapy. In patients having both higher BMI and viral load, cut-off levels of 150 and 600 pg/mL yielded a positive predictive value (PPV) of 71% and NPV of 100%, respectively. In conclusion, pretreatment IP-10 levels predict RVR and SVR in patients infected with HCV genotype 1, even in those with higher BMI and viral load. A substantial proportion of the latter patients may achieve SVR in spite of unfavorable baseline characteristics if their pretreatment IP-10 level is low. Thus, pretreatment IP-10 analysis may prove helpful in decision-making regarding pharmaceutical intervention.</p

Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage

Background We investigated two distinct synovial fibroblast populations that were located preferentially in the lining or sub-lining layers and defined by their expression of either podoplanin (PDPN) or CD248, and explored their ability to undergo self-assembly and transmigration in vivo. Methods Synovial fibroblasts (SF) were cultured in vitro and phenotypic changes following stimulation with interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β1 were examined. To examine the phenotype of SF in vivo, a severe combined immunodeficiency (SCID) human-mouse model of cartilage destruction was utilised. Results SF in the lining layer in rheumatoid arthritis (RA) expressed high levels of PDPN compared to the normal synovium, whereas CD248 expression was restricted to sub-lining layer cells. TNF-α or IL1 stimulation in vitro resulted in an increased expression of PDPN. In contrast, stimulation with TGF-β1 induced CD248 expression. In the SCID human-mouse model, rheumatoid SF recapitulated the expression of PDPN and CD248. Fibroblasts adjacent to cartilage expressed PDPN, and attached to, invaded, and degraded cartilage. PDPN+ CD248– SF preceded the appearance of PDPN– CD248+ cells in contralateral implants. Conclusions We have identified two distinct SF populations identified by expression of either PDPN or CD248 which are located within different anatomical compartments of the inflamed synovial membrane. These markers discriminate between SF subsets with distinct biological properties. As PDPN-expressing cells are associated with early fibroblast migration and cartilage erosion in vivo, we propose that PDPN-expressing cells may be an attractive therapeutic target in RA.</p

Мероприятия по предупреждению травматизма на ООО "Газпром Трансгаз Томск"

A series of macrocyclic peptidic BACE-1 inhibitors was designed. While potency on BACE-1 was rather high, the first set of compounds showed poor brain permeation and high efflux in the MDCK-MDR1 assay. The replacement of the secondary benzylamino group with a phenylcyclopropylamino group maintained potency on BACE-1, while p-glycoprotein-mediated efflux was significantly reduced and brain permeation improved. Several compounds from this series demonstrated acute reduction of Abeta in human APP-wildtype transgenic (APP51) mice after oral administration